Atrial Fibrillation in Young Patients: a Prospective Multicentre Registry
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Atrial Fibrillation, Lone Atrial Fibrillation. Basic parameters: up to 35 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Atrial fibrillation is a rare cardiac arrhythmia in young (i.e. \<= 35-year-old) patients. Etiological factors, current management and mid- to long-term outcomes remain unknown.
Detailed description
Atrial Fibrillation in YOUNG patients (YOUNG-AF) is a prospective, observational, multicentric registry, including every consecutive patients aged \< 35-year-old with a diagnosis of atrial fibrillation. The registry will assess demographical, physical activity, toxicologic and genetic factors, as well as current management regarding anticoagulation, anti-arrhythmic drugs and catheter ablation. As an observational registry, patient will be managed with the guidelines-directed standard-of-care.
Primary outcome measures
- Composite of mortality, thromboembolic event and heart failure [Time frame: at 10-year]
- Recurrent symptomatic atrial fibrillation. [Time frame: at 10-year]
Eligibility criteria
Inclusion criteria
- First episode of atrial fibrillation
- Less than 35-year-old
- Diagnostic by 12-lead ECG or continuous monitoring (minimal duration 30 seconds)
- French Social Security number
Exclusion criteria
- Transvenous cardiac implantable electronic device (insertable cardiac monitors are not an exclusion criteria)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
France · 1 center
- Caen University Hospital — Caen
Identifiers
NCT: NCT04776759 · Rythmo20200901